Literature DB >> 1815028

Biochemical and antigenic characterization of mannoprotein constituents released from yeast and mycelial forms of Candida albicans.

A Torosantucci1, M J Gomez, C Bromuro, I Casalinuovo, A Cassone.   

Abstract

Yeast or mycelial cultures of Candida albicans released comparable amounts of Concanavalin A-reactive mannoprotein material after 24-h of growth, and in both cases this material showed a qualitatively similar SDS-PAGE pattern, with predominantly polydisperse constituents of high molecular mass. The two secretion mixtures also showed similar reactivity by ELISA with serum from a subject with high titre anti-Candida antibodies, as well as with an anti-Candida hyperimmune antiserum raised in rabbits. Both secreted extracts were separated by ion-exchange chromatography into two major fractions (designated F1 and F2), each containing mannoprotein antigens recognized by rabbit and human sera, although the immunoreactivity of the two fractions from the two growth forms was not uniform. The mannoproteins released from mycelial cultures, in particular those present in the F1 fraction, were poorly reactive or not reactive at all in ELISA with a monoclonal antibody (mAbAF1) which strongly recognized the material released from yeast cultures. Immunoblots of the more acidic, more antigenic F2 fractions with mAbAF1 and polyclonal anti-Candida antisera demonstrated that the monoclonal antibody did not recognize several mannoprotein molecules which were recognized by the polyclonal antibodies, in particular a 45-47 kDa component present only in the secreted extract from mycelium. A quantitative ELISA-inhibition method showed that the rate of release of mannoprotein antigen during growth in the yeast form was either constant (as assayed with polyclonal antibodies) or fluctuated without any definite trend (as seen with mAbAF1). On the other hand, cultures of mycelial cells exhibited an early (90 min) peak of antigen release, followed by either a decrease to a rate corresponding to that of yeast cells (with polyclonal antibodies) or a total lack of secretion (with mAbAF1). This modulation in the secretion of mAbAF1 reactive molecules was temporarily associated with germ tube emergence-elongation, and was not observed in an agerminative mutant of C. albicans grown under germination permissive conditions. These results highlight the dynamic aspects of the secretion of specific mannoprotein epitopes released from C. albicans during hyphal growth, and the direct relationship between this release and the dynamic expression of the same epitopes on the cell surface demonstrated previously.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1815028     DOI: 10.1080/02681219180000591

Source DB:  PubMed          Journal:  J Med Vet Mycol        ISSN: 0268-1218


  16 in total

1.  Purification and biochemical characterization of a 65-kilodalton mannoprotein (MP65), a main target of anti-Candida cell-mediated immune responses in humans.

Authors:  M J Gomez; A Torosantucci; S Arancia; B Maras; L Parisi; A Cassone
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

2.  Biochemical and immunological characterization of MP65, a major mannoprotein antigen of the opportunistic human pathogen Candida albicans.

Authors:  M J Gomez; B Maras; A Barca; R La Valle; D Barra; A Cassone
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

Review 3.  Cell wall and secreted proteins of Candida albicans: identification, function, and expression.

Authors:  W L Chaffin; J L López-Ribot; M Casanova; D Gozalbo; J P Martínez
Journal:  Microbiol Mol Biol Rev       Date:  1998-03       Impact factor: 11.056

4.  Differentiation of Candida albicans and Candida dubliniensis by using recombinant human antibody single-chain variable fragments specific for hyphae.

Authors:  Joseph M Bliss; Mark A Sullivan; Jane Malone; Constantine G Haidaris
Journal:  J Clin Microbiol       Date:  2003-03       Impact factor: 5.948

5.  Preliminary characterization of the material released to the culture medium by Candida albicans yeast and mycelial cells.

Authors:  J L López-Ribot; D Gozalbo; P Sepúlveda; M Casanova; J P Martínez
Journal:  Antonie Van Leeuwenhoek       Date:  1995-10       Impact factor: 2.271

6.  Isolation and characterization of yeast monomorphic mutants of Candida albicans.

Authors:  M V Elorza; R Sentandreu; J Ruiz-Herrera
Journal:  J Bacteriol       Date:  1994-04       Impact factor: 3.490

7.  New approach for diagnosis of candidemia based on detection of a 65-kilodalton antigen.

Authors:  Rodrigo Berzaghi; Arnaldo Lopes Colombo; Antonia Maria de Oliveira Machado; Zoilo Pires de Camargo
Journal:  Clin Vaccine Immunol       Date:  2009-09-23

8.  Interplay between protective and inhibitory antibodies dictates the outcome of experimentally disseminated Candidiasis in recipients of a Candida albicans vaccine.

Authors:  Carla Bromuro; Antonella Torosantucci; Paola Chiani; Stefania Conti; Luciano Polonelli; Antonio Cassone
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

9.  Use of a monoclonal antibody in a dot immunobinding assay for detection of a circulating mannoprotein of Candida spp. in neutropenic patients with invasive candidiasis.

Authors:  F De Bernardis; C Girmenia; M Boccanera; D Adriani; P Martino; A Cassone
Journal:  J Clin Microbiol       Date:  1993-12       Impact factor: 5.948

10.  Modulation of cell surface-associated mannoprotein antigen expression in experimental candidal vaginitis.

Authors:  F De Bernardis; A Molinari; M Boccanera; A Stringaro; R Robert; J M Senet; G Arancia; A Cassone
Journal:  Infect Immun       Date:  1994-02       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.